Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



PLECTRANTHUS AMBOINICUS: A REVIEW ON ITS PHARMACOLOGICAL AND, PHARMACOGNOSTICAL STUDIES.

PUNET KUMAR,SANGAM SINGH,NITIN KUMAR.




Abstract

In this review, information regarding phytochemistry, traditional uses, medicinal uses, side effects and future perspectives of Plectranthus amboinicus are given. Plectranthus amboinicus has been used in herbal medicines for the treatment of various disorders like asthma, flu, eczema and cardiovascular disorders. The plant possesses medicinal properties (such as antimicrobial activity, antifungal activity, anti-inflammatory activity, antidiabetic activity, anxiolytic activity, antineoplastic, analgesic, antimalarial, anti-biofilm efficacy, diuretic, wound healing activity, skincare, respiratory disorders, anti-platelet aggregation activity) due to the presence of various important constituents or secondary metabolites such as flavonoids, glycosides, phenols, tannins, and steroids, which have been identified via various spectroscopic methods. The different parts of the plant have used to prepare medicines. Owing to the presence of various important constituents, this plant can be used for medicines without side effects.

Key words: Plectranthus Ambonicus; Phytochemicals; Antineoplastic activity; Antifungal activity; Antimicrobial activity; alcoholic extract.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.